SCHEMBL7476300

SCHEMBL7476300

C[Si](C)(C)CCOCc1[nH]c(-c2cccc(C(F)(F)F)c2)nc1Br

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
THRB P10828 1/20 0.41
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.41
STAT6 P42226 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6984533 0.72 DGAT1 (0.43) CYP1A2CYP2C9NPSR1KDM4EALDH1A1
SCHEMBL6982954 0.70 DGAT1 (0.58) CYP1A2CYP2C9NPSR1KDM4EALDH1A1
SCHEMBL19398619 0.65 KCNH2 (0.53) ALDH1A1MEN1NPC1RAB9AKMT2A
SCHEMBL311704 0.65 CXCR1 (0.43) CYP1A2CYP3A4KDM4EALDH1A1HPGD
SCHEMBL13607863 0.64 CYP1A2 (0.53) PIN1CYP1A2CYP3A4CYP2C9NPSR1
SCHEMBL6651603 0.63 PIN1 (0.60) PIN1CYP1A2CYP3A4CYP2C9NPSR1
SCHEMBL11562962 0.63 PIN1 (0.63) PIN1CYP1A2CYP3A4CYP2C9NPSR1
SCHEMBL1720364 0.63 CYP1A2 (0.55) PIN1CYP1A2CYP3A4CYP2C9NPSR1
SCHEMBL24074350 0.62 NPBWR1 (0.59) PIN1CYP1A2CYP3A4CYP2C9NPSR1
SCHEMBL20445314 0.62 MAPK14 (0.61) PIN1CYP1A2CYP3A4CYP2C9NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224180-A2 SUBSTITUTED AZOLES Novartis AG (CH) 2002-07-24 EP disclosed
WO-2000063204-A2 SUBSTITUTED AZOLES NOVARTIS AG (CH) 2000-10-26 WO disclosed